Technology

Vaccine start-ups return to the World Vaccine Congress!

Vaccine start-ups return to the World Vaccine Congress!

In the last few weeks before the World Vaccine Congress in Barcelona, our start-up zone is reaching capacity! This week we are pleased to present another set of organisations that have already secured their spaces in the zone. To see previous introductions head over...

Cambridge shares further antigen technology success

Cambridge shares further antigen technology success

The University of Cambridge announced in September 2023 that a vaccine antigen technology developed in collaboration with spin-out DIOSynVax in early 2020 demonstrated protection against all known variants of SARS-CoV-2 and other major coronaviruses. With a paper...

UKHSA and CSL Seqirus partnership: flu pandemic preparation

UKHSA and CSL Seqirus partnership: flu pandemic preparation

In September the UKHSA announced an agreed deal for “millions of life-saving vaccines” has been signed with CSL Seqirus. The advance purchase agreement (APA) ensures that CSL Seqirus is “on standby” to produce over 100 million influenza vaccines if an influenza...

Vir Biotechnology begins Phase I HIV vaccine trial

Vir Biotechnology begins Phase I HIV vaccine trial

In September 2023 Vir Biotechnology announced that the first participant in a Phase I trial has been dosed. The trial of VIR-1388 will evaluate the safety, reactogenicity, and immunogenicity of the investigational novel T cell vaccine for the prevention of human...

Google’s DeepMind shares catalogue of disease insights

Google’s DeepMind shares catalogue of disease insights

In September 2023 Google’s AI organisation, DeepMind, released a catalogue of genetic mutations intended to accelerate disease diagnosis and enable improvements to medical interventions. DeepMind, a team of “scientists, engineers, ethicists, and more” is “committed to...

Bio Farma and CEPI forge 10-year vaccine partnership

Bio Farma and CEPI forge 10-year vaccine partnership

In September 2023 CEPI and Bio Farmer announced the agreement of a 10-year partnership to “boost rapid manufacturing of outbreak vaccines” at Indonesia’s “leading” vaccine manufacturer. This partnership is intended to bring mRNA and viral vector rapid response vaccine...

Vaccine start-ups return to the World Vaccine Congress!

Vaccine start-ups return to the World Vaccine Congress!

With less than a month until the World Vaccine Congress in Barcelona, our start-up zone is continuing to grow! This week we are pleased to present another set of organisations that have already secured their spaces in the zone. To see previous introductions head over...